UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents

The Journal of clinical investigation, 2011-08, Vol.121 (8), p.3005-3023

2011

Volltextzugriff (PDF)

Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade

Journal of Alzheimer's disease, 2016-10, Vol.54 (4), p.1629

2016

Volltextzugriff (PDF)

A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R

The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5699-5708

2002

Volltextzugriff (PDF)

Perlecan Domain V induces VEGf secretion in brain endothelial cells through integrin α5β1 and ERK-dependent signaling pathways

PloS one, 2012-09, Vol.7 (9), p.e45257

2012

Volltextzugriff (PDF)

Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function

Journal of Alzheimer's disease, 2014-01, Vol.38 (2), p.415

2014

Volltextzugriff (PDF)

Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin

Cancer chemotherapy and pharmacology, 2011-06, Vol.67 (6), p.1389-1400

2011

Volltextzugriff (PDF)

A Battery Powered, Portable, and Self-Contained Non-Thermal Helium Plasma Jet Device for Point-of-Injury Burn Wound Treatment

Plasma processes and polymers, 2015-11, Vol.12 (11), p.1244-1255

2015

Volltextzugriff (PDF)

A Battery Powered, Portable, and Self-Contained Non-Thermal Helium Plasma Jet Device for Point-of-Injury Burn Wound Treatment: A Battery Powered, Portable and Self-Contained

Plasma processes and polymers, 2015-11, Vol.12 (11), p.1244-1255

2015

Volltextzugriff (PDF)

Perlecan domain V inhibits α2 integrin-mediated amyloid-β neurotoxicity

Neurobiology of aging, 2012-07, Vol.33 (7), p.1379-1388

2012

Volltextzugriff (PDF)

Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitro

Brain research, 2010-11, Vol.1360, p.28-39

2010

Volltextzugriff (PDF)

Perlecan Domain V Induces VEGf Secretion in Brain Endothelial Cells through Integrin [alpha].sub.5[beta].sub.1 and ERK-Dependent Signaling Pathways

PloS one, 2012-09, Vol.7 (9), p.e45257

2012

Volltextzugriff (PDF)

Perlecan domain V inhibits I-2 integrin-mediated amyloid-I2 neurotoxicity

Neurobiology of aging, 2012-07, Vol.33 (7), p.1379-1388

2012

Volltextzugriff (PDF)

Non-viral delivery of nuclear factor-κB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis

Gut, 2007-04, Vol.56 (4), p.524-533

2007

Volltextzugriff (PDF)

Perlecan's domain V prevents amyloid-beta toxicity

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S584-S584

2011

Volltextzugriff (PDF)

P3‐213: Perlecan's domain V prevents amyloid‐beta toxicity

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_17), p.S584-S584

2011

Volltextzugriff (PDF)

Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents

The Journal of clinical investigation, 2012-02, Vol.122 (2), p.777-777

2012

Volltextzugriff (PDF)

Blockade of Experimental Atopic Dermatitis via Topical NF-κB Decoy Oligonucleotide

Journal of investigative dermatology, 2006-08, Vol.126 (8), p.1792-1803

2006

Volltextzugriff (PDF)

P3‐470: Perlecan domain V inhibits alpha 2 integrin mediated Abeta neurotoxicity

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_19), p.S591-S591

2010

Volltextzugriff (PDF)

The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor

The Journal of immunology (1950), 1997-01, Vol.158 (2), p.604

1997

Volltextzugriff (PDF)

Follicular dendritic cells specifically express the long CR2/CD21 isoform

The Journal of experimental medicine, 1997-01, Vol.185 (1), p.165-170

1997

Volltextzugriff (PDF)

Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis

Gut, 2007-04, Vol.56 (4), p.524

2007

Volltextzugriff (PDF)

Non-viral delivery of nuclear factor- B decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis

Gut, 2007-04, Vol.56 (4), p.524-533

2007

Volltextzugriff (PDF)

Blockade of Experimental Atopic Dermatitis via Topical NF- B Decoy Oligonucleotide

Journal of investigative dermatology, 2006-08, Vol.126 (8), p.1792-1803

2006

Volltextzugriff (PDF)

Blockade of experimental atopic dermatitis via topical NF-kappaB decoy oligonucleotide

Journal of investigative dermatology, 2006-08, Vol.126 (8), p.1792-1803

2006

Volltextzugriff (PDF)

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5699-5708

2002

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents

Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade

A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R

Perlecan Domain V induces VEGf secretion in brain endothelial cells through integrin α5β1 and ERK-dependent signaling pathways

Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function

Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin

A Battery Powered, Portable, and Self-Contained Non-Thermal Helium Plasma Jet Device for Point-of-Injury Burn Wound Treatment

A Battery Powered, Portable, and Self-Contained Non-Thermal Helium Plasma Jet Device for Point-of-Injury Burn Wound Treatment: A Battery Powered, Portable and Self-Contained

Perlecan domain V inhibits α2 integrin-mediated amyloid-β neurotoxicity

Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitro

Perlecan Domain V Induces VEGf Secretion in Brain Endothelial Cells through Integrin [alpha].sub.5[beta].sub.1 and ERK-Dependent Signaling Pathways

Perlecan domain V inhibits I-2 integrin-mediated amyloid-I2 neurotoxicity

Non-viral delivery of nuclear factor-κB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis

Perlecan's domain V prevents amyloid-beta toxicity

P3‐213: Perlecan's domain V prevents amyloid‐beta toxicity

Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents

Blockade of Experimental Atopic Dermatitis via Topical NF-κB Decoy Oligonucleotide

P3‐470: Perlecan domain V inhibits alpha 2 integrin mediated Abeta neurotoxicity

The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor

Follicular dendritic cells specifically express the long CR2/CD21 isoform

Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis

Non-viral delivery of nuclear factor- B decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis

Blockade of Experimental Atopic Dermatitis via Topical NF- B Decoy Oligonucleotide

Blockade of experimental atopic dermatitis via topical NF-kappaB decoy oligonucleotide

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Suchergebnisse filtern